WADAs Senior Director of Science and Medicine, Olivier Rabin, told Sky News that the organisation will be monitoring a change in paradigm. To elaborate: We want to see whether we detect patterns of abuse of this drug or this class of substances in sport So we keep an eye on them because there's been a change in paradigm in the way weight can be controlled because of those drugs
Do not use mechanism-of-action information as personal dosing or treatment advice
It purports to help prevent muscle loss, regulate blood sugar levels and minimize nausea and bloating
About 69% of semaglutide users lose at least 10% of body weight, compared to approximately 33% of Saxenda users
Weight data were available for 4,038 and 1,186 patients in the non-treated and semaglutide cohort, respectively
3.3 TB-500 What it is and what it is not